FDA Adverse Event Injury Summary report: N

THINLINE II STEROX

MDR report key: 1951421 · Received January 6, 2011

Report

Report Number
2124215-2010-23034
Event Type
Injury
Date Received
January 6, 2011
Date of Event
November 28, 2010
Report Date
November 28, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE ATRIAL LEAD REMAINS IMPLANTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE AN AMENDED REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT TWO DAYS POST IMPLANT, THIS ATRIAL LEAD BECAME DISLODGED. A REVISION PROCEDURE WAS PERFORMED; THE LEAD WAS SUCCESSFULLY REPOSITIONED AND REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 THINLINE II STEROX IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4370

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention